86 related articles for article (PubMed ID: 4358294)
1. The intravenous fat tolerance test with intralipid in various types of hyperlipidaemias and comparison between metabolism of intralipid and VLDL.
Rössner S
Adv Exp Med Biol; 1973; 38():69-85. PubMed ID: 4358294
[No Abstract] [Full Text] [Related]
2. Effects of oxandrolone on plasma lipoproteins and the intravenous fat tolerance in man.
Olsson AG; Orö L; Rössner S
Atherosclerosis; 1974; 19(2):337-46. PubMed ID: 4360244
[No Abstract] [Full Text] [Related]
3. [Hyperlipoproteinemia].
Meinders AE
Ned Tijdschr Geneeskd; 1979 Mar; 123(15):617-28. PubMed ID: 219378
[No Abstract] [Full Text] [Related]
4. Gonadal hormones and triglycerides.
Glueck CJ; Fallat R
Proc R Soc Med; 1974 Jun; 67(7):667-9. PubMed ID: 4368749
[No Abstract] [Full Text] [Related]
5. Progestagens, anabolic-androgenic compounds, estrogens: effects on triglycerides and postheparin lipolytic enzymes.
Glueck CJ; Scheel D; Fishback J; Steiner P
Lipids; 1972 Feb; 7(2):110-3. PubMed ID: 4551949
[No Abstract] [Full Text] [Related]
6. Studies on an intravenous fat tolerance test. Methodological, experimental and clinical experiences with Intralipid.
Rössner S
Acta Med Scand Suppl; 1974; 564():1-24. PubMed ID: 4376889
[No Abstract] [Full Text] [Related]
7. Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV.
Einarsson K; Hellström K; Leijd B
J Lab Clin Med; 1977 Oct; 90(4):613-22. PubMed ID: 198500
[No Abstract] [Full Text] [Related]
8. Bile acid metabolism in hyperlipoproteinaemia.
Hellström K; Einarsson K
Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
[No Abstract] [Full Text] [Related]
9. Xanthomatosis and hyperlipoproteinemia; a review.
Polano MK
Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
[No Abstract] [Full Text] [Related]
10. Treatment of hyperlipidemia.
Levy RI; Morganroth J; Rifkind BM
N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
[No Abstract] [Full Text] [Related]
11. [Effect of oxandrolone on the serum lipids in type IV and IIb hyperlipidemia].
Zorrilla E; Magos C; Serrano PA
Arch Inst Cardiol Mex; 1973; 43(2):270-8. PubMed ID: 4712792
[No Abstract] [Full Text] [Related]
12. Further methodological studies on the intravenous fat tolerance with Intralipid emulsion.
Rössner S
Scand J Clin Lab Invest; 1976 Mar; 36(2):155-9. PubMed ID: 1273493
[TBL] [Abstract][Full Text] [Related]
13. Hypolipidemic drugs.
Sirtori C; Fumagalli R; Paoletti R
Adv Exp Med Biol; 1973; 38():171-98. PubMed ID: 4594063
[No Abstract] [Full Text] [Related]
14. Effects of moderate exercise on VLDL₁ and Intralipid kinetics in overweight/obese middle-aged men.
Al-Shayji IA; Caslake MJ; Gill JM
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E349-55. PubMed ID: 22094472
[TBL] [Abstract][Full Text] [Related]
15. Effect of hypolipidemic drugs on serum lipoproteins.
Carlson LA; Olsson AG
Prog Biochem Pharmacol; 1979; 15():238-57. PubMed ID: 224397
[No Abstract] [Full Text] [Related]
16. [The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy].
Schwartzkopff W; Zschiedrich M
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():825-9. PubMed ID: 196436
[No Abstract] [Full Text] [Related]
17. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
[TBL] [Abstract][Full Text] [Related]
18. Lipid metabolism and classification of hyperlipaemias.
Real JT; Ascaso JF
Clin Investig Arterioscler; 2021 May; 33 Suppl 1():3-9. PubMed ID: 33966810
[TBL] [Abstract][Full Text] [Related]
19. Effect of l-carnitine on lipid pattern in debilitated patients treated with Intralipid.
Pola P; Tondi P; Flore R; Serricchio M; Dal Lago A; Amanti C; Consorti F; Benedetti M; Midiri H
Int J Clin Pharmacol Res; 1983; 3(3):179-84. PubMed ID: 6592157
[TBL] [Abstract][Full Text] [Related]
20. Differential drug therapy of the hyperlipoproteinaemias. Physiological rationale for differential drug therapy.
Levy RI
Postgrad Med J; 1975; 51(8):suppl 60-2. PubMed ID: 215982
[No Abstract] [Full Text] [Related]
[Next] [New Search]
